Jiayong Qiu

Dr. Jiayong Qiu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
YHYingying Hao
Yingying Hao
YZYingwei Zhu
Yingwei Zhu
YMYimin Mao
Yimin Mao
JXJingduan Xu
Jingduan Xu
XHXuegai He
Xuegai He
JQJiayong Qiu
Jiayong Qiu

24 November 2023 in Medicine
Verified
Journal Article
Open access
CDChaowei Ding
Chaowei Ding
ZZZiping Mm Zhang
Ziping Mm Zhang
JQJiayong Qiu
Jiayong Qiu
DDdu dan
du dan
ZLZexin Liu
Zexin Liu
Red blood cell distribution width (RDW) to human serum albumin (ALB) ratio (RDW/ALB Ratio, RAR) is a prognostic factor for adverse outcomes in different disease populations. However, the relationship between RAR and pulmonary embolism outcomes remains unclear. Therefore, this study set out to investigate the association between RAR and the risk of all-cause death in acute pulmonary embolism (APE) patients admitted to the intensive care unit (ICU). This is a retrospective study based on the MIMIC-IV database. The primary outcome was all-cause mortality among patients with APE (in-hospital and 1-year mortality). The relationship between RAR and all-cause mortality was assessed using Cox regression analysis. The survival curve was drawn to evaluate the predictive value of RAR for patient mortality. Correlations and threshold effects between RAR and all-cause mortality were analyzed using the generalized additive model (GAM). The study included 773 patients, and fully adjusted Cox regression models showed that RAR was associated with higher all-cause mortality in the hospital and one year later (all P < .05). In the GAM, the relationship between RAR and all-cause mortality was shown to be nonlinear, with a positive association between RAR and all-cause mortality in APE patients when RAR values were at low to moderate levels. This study revealed a significant association between RAR and the risk of all-cause day death in patients with pulmonary embolism. Higher RAR value was associated with increased in-hospital mortality and 1-year mortality.

4 April 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
CDChaowei Ding
Chaowei Ding
SHShen-Shen Huang
Shen-Shen Huang
YXYan-Hong Xu
Yan-Hong Xu
XCXu Chu
Xu Chu
LWLan Wang
Lan Wang
JQJiayong Qiu
Jiayong Qiu
Chronic obstructive pulmonary disease (COPD) is a global public health challenge and a major cause of death. The lactate dehydrogenase to albumin ratio (LAR) is a simple and practical indicator of disease prognosis, but its prognostic value in acute exacerbation of COPD (AECOPD) remains unclear. Therefore, we aimed to explore the prognostic value of LAR for the short-term all-cause mortality risk in patients with AECOPD. This retrospective cohort study included 654 patients with AECOPD from the MIMIC-IV database. LAR was analyzed after natural logarithm transformation and the patients were divided into three groups. The clinical outcome was the 1-month and 3-months all-cause mortality. The relationship between LAR and all-cause mortality was assessed using Kaplan–Meier survival analysis and a Cox regression model. Generalized additive models were employed to identify non-linear relationships, and a subgroup analysis was performed to determine the stability of the results. The study showed that LAR levels significantly and positively correlated with short-term all-cause mortality in patients with AECOPD. Compared to the low LAR group, patients in the medium LAR group had a significantly increased 1-month all-cause mortality risk, with a hazard ratio (HR) of 1.74 (95% [Confidence Interval, CI] 1.16–2.63, P = 0.008). Patients in the high LAR group had an even higher 1-month all-cause mortality risk, with an HR of 2.58 (95% CI 1.75–3.80, P < 0.001). For 3-month all-cause mortality, patients in the medium LAR group had an HR of 1.54 (95% CI 1.10–2.16, P = 0.012), while those in the high LAR group had an HR of 2.18 (95% CI 1.58–3.01, P < 0.001). The results remained stable in all three adjusted models and in the subgroup analyses. The relationship between LAR and all-cause mortality due to AECOPD was non-linear, with inflection points at 8.13 and 6.05 for 1-month and 3-month all-cause mortality, respectively. Elevated LAR is an independent predictive indicator of short-term all-cause mortality risk in patients with AECOPD and can be used to improve decision-making for the clinical management of these patients. Not applicable.

9 January 2024 in Angiology
Verified
Journal Article
Closed access
JQJiayong Qiu
Jiayong Qiu
YHYingying Hao
Yingying Hao
SHShenshen Huang
Shenshen Huang
TWTongsheng Wang
Tongsheng Wang
XHXuegai He
Xuegai He
YYYadong Yuan
Yadong Yuan
The relationship between serum albumin (ALB) and short-term prognosis in patients with acute pulmonary embolism (APE) remains unclear. We investigated the predictive value of ALB for short-term prognosis in APE patients using our hospital pulmonary embolism (PE) database (384 patients consecutively collected). Logistic regression analysis and nomograms were applied to construct the predictive model, and validation was assessed. A total of 340 APE patients were included, with a 30-day all-cause mortality rate of 8.5%. The incidence of hypoalbuminemia was 15.9%. The odds ratio (OR) for short-term mortality in patients with high ALB was 0.89 (0.886, 95% CI: 0.812–0.967). Additionally, we created a nomogram for individualized mortality risk prediction. Receiver operating characteristic (ROC) curve analysis showed that the diagnostic area under the curve (AUC) of ALB was 0.758 (95% CI 0.683–0.833), and the best cut-off value was 33.85 g/L. Optimal simplified Pulmonary Embolism Severity Index (sPESI) (ALB combined sPESI) AUC was 0.835 (95% CI 0.775–0.896). Baseline hypoalbuminemia may be an independent prognostic indicator of short-term mortality in patients with APE.

18 April 2024 in International Journal of Cardiology
Verified
Journal Article
Closed access
CDChao-Wei Ding
Chao-Wei Ding
CLChao Liu
Chao Liu
ZZZi-Ping Zhang
Zi-Ping Zhang
CCChun-Yan Cheng
Chun-Yan Cheng
GPGuang-Sheng Pei
Guang-Sheng Pei
JQJiayong Qiu
Jiayong Qiu

19 January 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
JQJiayong Qiu
Jiayong Qiu
YLYao Lou
Yao Lou
YZYingwei Zhu
Yingwei Zhu
MWMin Wang
Min Wang
HPHuifang Peng
Huifang Peng
YMYi min Mao
Yi min Mao
Background: Birt-Hogg-Dubé (BHD) syndrome and congenital contractural arachnodactyly (CCA) or Beals-Hecht syndrome are clinically rare autosomal dominant genetic diseases. In this study, we describe an extremely rare family with BHD syndrome and CCA.Objective: To investigate the clinical and genetic characteristics of a family with BHD syndrome and CCA.Methods: We describe the clinical characteristics, family history, and clinical manifestations of the patient’s family members. The patient underwent a blood test, computed tomography (CT) of the chest, color Doppler ultrasound of the abdomen and heart, and digital radiography of the hands. Whole exome sequencing was performed on his family members.Results: Two years ago, the male proband developed chest tightness and shortness of breath that was accompanied by an irritating cough as well as repeated (four times) spontaneous pneumothorax. The chest CT indicated spontaneous pneumothorax on the right side and cyst and bullae in both lungs. He had no kidney tumors or skin lesions. His son had a history of pulmonary bullae and experienced spontaneous pneumothorax twice. The proband, his mother, and his son were all born with a hand deformity. The sequencing results demonstrated that both the proband and his son had heterozygous variations of the folliculin (FLCN) gene c.1015C > T (p. Gln339Ter) and fibrillin-2 (FBN2) gene c.3485G > A (p. Cys1162Tyr), which are associated with BHD syndrome and CCA, respectively.Conclusion: For patients with chest tightness, shortness of breath, recurrent spontaneous pneumothorax, and congenital hand deformity without inducement, genetic testing should be carried out as soon as possible to make a clear diagnosis, which can then guide treatment and genetic counseling.